SEC Form 4 · accession 0001225208-17-010881
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur C Butcher
Officer — SVP&Pres, Endoscopy
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2017 | M | 1,761 | $0.00 | A | 15,370 | D | |
| Common Stock | Jun 1, 2017 | F | 829 | $27.61 | D | 14,541 | D | |
| Common Stock | holding | — | — | — | 2,564 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF1,F2 | — | Jun 1, 2017 | M | 1,761 | D | Jun 1, 2021 | Jun 1, 2021 | Common Stock | 1,761 | 7,045 | D |
Explanation of responses
- F1Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F2Shares of common stock will be issued to the reporting person in five equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant.